help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber-Matthiesen, K.
Right arrow Articles by Schlegelberger, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber-Matthiesen, K.
Right arrow Articles by Schlegelberger, B.

American Journal of Pathology, Vol 149, 463-468, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics

K Weber-Matthiesen, J Deerberg-Wittram, A Rosenwald, M Poetsch, W Grote and B Schlegelberger
Department of Human Genetics, University of Kiel, Germany.

A number of neoplastic disorders are characterized by recurrent chromosome aberrations. One of these is the translocation t(2;5), which is found in a considerable percentage of large-cell anaplastic lymphomas. This translocation results in the fusion of two genes, alk and npm. The recent discovery of alk/npm mRNA in 11 of 13 cases of Hodgkin's disease has caused a controversial discussion concerning the question of whether t(2;5) is also present in Hodgkin and Reed- Sternberg cells. We tackled this problem on the molecular cytogenetic level by combined CD30 immunophenotyping and interphase cytogenetics. Using a pair of DNA probes flanking both sides of the npm gene breakpoint at 5q35 we were able to prove, at least in 12 of 13 cases of Hodgkin's disease, that all CD30-positive Hodgkin and Reed-Sternberg cells lacked the translocation t(2;5). Fifteen to forty-five Hodgkin/Reed-Sternberg cells were analyzed per case (mean, 27). Our findings indicate that this translocation is not a primary event in the development of Hodgkin's disease.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. I. Martin-Subero, I. Chudoba, L. Harder, S. Gesk, W. Grote, F. J. Novo, M. J. Calasanz, and R. Siebert
Multicolor-FICTION: Expanding the Possibilities of Combined Morphologic, Immunophenotypic, and Genetic Single Cell Analyses
Am. J. Pathol., August 1, 2002; 161(2): 413 - 420.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Camilleri-Broet, J. Audouin, C. Ferme, J. Briere, K. Pulford, P. Gaulard, M. Divine, E. Macintyre, G. Delsol, and F. Berger
ALK is not expressed in Hodgkin disease
Blood, March 15, 2001; 97(6): 1901 - 1902.
[Full Text] [PDF]


Home page
BloodHome page
A. Rosenwald, G. Ott, K. Pulford, T. Katzenberger, J. Kuhl, J. Kalla, M. M. Ott, D. Y. Mason, and H. K. Muller-Hermelink
t(1;2)(q21;p23) and t(2;3)(p23;q21): Two Novel Variant Translocations of the t(2;5)(p23;q35) in Anaplastic Large Cell Lymphoma
Blood, July 1, 1999; 94(1): 362 - 364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.